SEC Insider Transactions from Issa Mohamed Khairie.

Last updated: 2026-03-14 11:45 UTC | Total transactions: 8

Issa Mohamed Khairie, EVP and Head of US Oncology at Incyte Corp ($INCY), sold shares on the open market once in the last year, totaling about $1.18 million. His most recent sale occurred on January 7, 2026. These sales rank him 4,547th among 11,678 insiders in our database by total value sold, below the average of $8.6 million across about 6.4 transactions per insider. He made no open market purchases during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 16, 2026 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology A Employee Stock Option (right to buy) 14237 $0.00 14,237.0000 200,700,000 9999.99% 0.01%
Jan. 7, 2026 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology S Common Stock 10856 $109.07 66,132.0000 200,700,000 14.10% 0.01%
Jan. 6, 2026 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology F Common Stock 8264 $106.66 76,988.0000 200,700,000 9.69% 0.00%
July 15, 2025 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology A Common Stock 8769 $0.00 85,252.0000 210,530,000 11.47% 0.00%
July 15, 2025 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology A Performance Shares 21923 $0.00 21,923.0000 210,530,000 9999.99% 0.01%
July 15, 2025 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology A Employee Stock Option (right to buy) 19735 $0.00 19,735.0000 210,530,000 9999.99% 0.01%
June 30, 2025 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology A Common Stock 27812 $0.00 76,483.0000 210,530,000 57.14% 0.01%
Jan. 6, 2025 INCYTE CORP $INCY Issa Mohamed Khairie EVP, Head of US Oncology A Common Stock 48671 $0.00 48,671.0000 210,530,000 9999.99% 0.02%